Dr. David A. Vorchheimer, MD

Dr. Vorchheimer practices at New Hyde Park Endoscopy in Lake Success, New York.

Dr. Vorchheimer's NPI, 1952323180, was assigned on July 24, 2006. Dr. Vorchheimer graduated from Albert Einstein College of Medicine of Yeshiva University in 1987. Dr. Vorchheimer holds New York license 175854.

Dr. Vorchheimer's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Dr. Vorchheimer's primary practice is New Hyde Park Endoscopy in Lake Success, New York. Dr. Vorchheimer is also affiliated with Lenox Hill Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Vorchheimer to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vorchheimer practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Vorchheimer's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Vorchheimer is licensed in New York.

CMS data shows 1,519 Medicare services from Dr. Vorchheimer across 13 procedure codes in 2024, for 297 Medicare patients. Medicare paid $92,816 for them. Every service was in an office.

CMS counts 297 Medicare patients who saw Dr. Vorchheimer in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vorchheimer's median patient age at 63, with 41% women.

In 2024, Dr. Vorchheimer wrote 1,137 Medicare Part D claims for 187 patients. 75% of them were for generic drugs. CMS names the drug for 940 of them, across 24 drugs with 11 or more claims each, at $251,988 in total drug cost. In 2023, CMS named 551 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Vorchheimer for performance year 2024, reported through an alternative payment model (APM). Dr. Vorchheimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vorchheimer as offering telehealth.

Dmand AI links 4 papers to Dr. Vorchheimer, published from 2014 to 2022. The most frequent topics are Atrial Fibrillation. Dr. Vorchheimer's most frequent co-authors are Usman Baber, MD, Robert Faillace, MD and Daniele Massera, MD.

CMS Open Payments shows 47 general payments to Dr. Vorchheimer from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 89% of the total. Sanofi and Genzyme US Companies paid the most, $15,437.

Dr. Vorchheimer graduated from Albert Einstein College of Medicine of Yeshiva University in 1987.